Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies

By Deenen Maarten  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1557-1565

Springer Publishing Company

Access to resources Recommend Favorite

A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors

By Hilgers Werner   Faivre Sandrine   Chieze Stéphanie   Alexandre Jérôme   Lokiec François   Goldwasser François   Raymond Eric   Kahatt Carmen   Taamma Abdelkrim   Weems Garry   MacDonald John   Misset Jean-Louis   Cvitkovic Esteban  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 311-319

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid®) in patients with advanced solid tumors

By Kalmadi S.   Davis M.   Dowlati A.   O’Keefe S.   Cline-Burkhardt M.   Pelley R.   Borden E.   Dreicer R.   Bukowski R.   Mekhail T.  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 211-216

Springer Publishing Company

Access to resources Recommend Favorite

A phase I Study with oral SU5416 in patients with advanced solid tumors: A drug inducing its clearance

By Salzberg Marc   Pless Miklos   Rochlitz Christoph   Ambrus Klara   Scigalla Paul   Herrmann Richard  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 299-304

Springer Publishing Company

Access to resources Recommend Favorite

A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors

By Delaunoit Thierry   Burch Patrick   Reid Joel   Camoriano John   Kobayash Tomowo   Braich Theodore   Kaur Judith   Rubin Joseph   Erlichman Charles  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 327-333

Springer Publishing Company

Access to resources Recommend Favorite